tiprankstipranks
Advertisement
Advertisement

ALT Stock Latest News

Altimmune Maintained at Buy as Late-Stage Liver Programs Advance and $20 Price Target Remains Unchanged
RatingsAltimmune Maintained at Buy as Late-Stage Liver Programs Advance and $20 Price Target Remains Unchanged
5d ago
ALT
Altimmune reports Q2 EPS (12c), consensus (12c)
PremiumThe Fly
Altimmune reports Q2 EPS (12c), consensus (12c)
6d ago
ALT
Marathon, Phillips 66, Clean Energy Fuels, Altimmune, Eaton Insider Shake‑Up
PremiumWeekend Updates
Marathon, Phillips 66, Clean Energy Fuels, Altimmune, Eaton Insider Shake‑Up
7d ago
ALT
ETN
Is ALT a Buy, Before Earnings?
PremiumPre-Earnings
Is ALT a Buy, Before Earnings?
13d ago
ALT
ALT Earnings Report this Week: Is It a Buy, Ahead of Earnings?
PremiumPre-Earnings
ALT Earnings Report this Week: Is It a Buy, Ahead of Earnings?
19d ago
ALT
Altimmune initiates PERFORMA trial
PremiumThe FlyAltimmune initiates PERFORMA trial
19d ago
ALT
Altimmune’s RECLAIM Study Adds an Addiction Angle to Its Obesity Drug
Premium
Company Announcements
Altimmune’s RECLAIM Study Adds an Addiction Angle to Its Obesity Drug
22d ago
ALT
Barclays says trial data highlights meaningful opportunity for Altimmune in AUD
Premium
The Fly
Barclays says trial data highlights meaningful opportunity for Altimmune in AUD
25d ago
ALT
H.C. Wainwright sees ‘clear Phase 2 win’ for Altimmune
PremiumThe Fly
H.C. Wainwright sees ‘clear Phase 2 win’ for Altimmune
25d ago
ALT
Leerink remains bullish on Altimmune following ‘positive’ AUD trial results
PremiumThe Fly
Leerink remains bullish on Altimmune following ‘positive’ AUD trial results
25d ago
ALT
Unusually active option classes on open July 28th
PremiumThe Fly
Unusually active option classes on open July 28th
25d ago
ALT
HTZ
Altimmune Reports Positive Phase 2 Data in AUD
PremiumCompany Announcements
Altimmune Reports Positive Phase 2 Data in AUD
25d ago
8K
ALT
Altimmune announces RECLAIM trial met primary endpoint
PremiumThe FlyAltimmune announces RECLAIM trial met primary endpoint
25d ago
ALT
BWXT, Altimmune, Global Payments, AbbVie, Nike Trending With Analysts
Premium
Weekend Updates
BWXT, Altimmune, Global Payments, AbbVie, Nike Trending With Analysts
2M ago
ALT
GPN
Unusually active option classes on open June 24th
Premium
The Fly
Unusually active option classes on open June 24th
2M ago
BP
ALT
Altimmune initiated with an Outperform at Leerink
PremiumThe Fly
Altimmune initiated with an Outperform at Leerink
2M ago
ALT
Altimmune initiated with an Outperform at Leerink
PremiumThe Fly
Altimmune initiated with an Outperform at Leerink
2M ago
ALT
Altimmune Relocates Corporate Headquarters to Morristown, New Jersey
PremiumCompany Announcements
Altimmune Relocates Corporate Headquarters to Morristown, New Jersey
2M ago
8K
ALT
Altimmune reports 48-week data from IMPACT Phase 2b trial of pemvidutide
PremiumThe Fly
Altimmune reports 48-week data from IMPACT Phase 2b trial of pemvidutide
3M ago
ALT
Altimmune price target lowered to $20 from $25 at H.C. Wainwright
PremiumThe FlyAltimmune price target lowered to $20 from $25 at H.C. Wainwright
3M ago
ALT
Altimmune price target lowered to $11 from $14 at Citizens
Premium
The Fly
Altimmune price target lowered to $11 from $14 at Citizens
3M ago
ALT
Altimmune Earnings Call: Cash Boost and Phase III Push
Premium
Company Announcements
Altimmune Earnings Call: Cash Boost and Phase III Push
3M ago
ALT

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >